M87.180

Clinical Causes: Use of bisphosphonates, such as alendronate or zoledronic acid, which are commonly prescribed for osteoporosis and cancer-related bone conditions. Administration of other antiresorptive agents that affect bone turnover. Recent dental surgeries or invasive dental procedures, like tooth extractions or implants, especially in patients taking these medications. Prolonged or high-dose use of certain medications that impair blood supply to the jawbone. Pre-existing dental infections or poor oral health, which can predispose the jaw to necrosis when combined with drug therapy.

Key Symptoms: Pain or discomfort in the jawbone Swelling or redness of the gums surrounding the jaw Loose teeth or pain around dental areas Infection that may cause pus discharge Exposed bone in the mouth that does not heal over time Numbness or a sensation of heaviness in the jaw Difficulty opening the mouth or chewing

Diagnosis Path: Diagnosis typically involves a combination of patient history, focusing on recent use of medications associated with osteonecrosis, and clinical examination. Dental imaging techniques like X-rays, CT scans, or MRI can reveal areas of bone death, bone exposure, and the extent of damage. Sometimes, a biopsy might be performed to confirm the diagnosis. It is important to distinguish osteonecrosis due to drugs from other jaw conditions for appropriate management.

Treatment Protocols: Managing osteonecrosis of the jaw involves multidisciplinary care. Interventions may include: - Discontinuing or modifying offending medications under medical guidance. - Preserving oral hygiene and managing infections with antibiotics. - Surgical procedures to remove necrotic bone tissue. - Pain management with appropriate medications. - Use of regenerative therapies like bone grafts in severe cases. - Regular dental visits for monitoring and preventive care. It is crucial to work closely with healthcare professionals to develop an individualized treatment plan and prevent further complications.